Weight Loss Support

Retatrutide

Triple-agonist research compound targeting GLP-1, GIP, and glucagon receptors.

Tirzepatide

Dual GIP / GLP-1 receptor agonist. Widely studied in metabolic and incretin research.

Semaglutide

GLP-1 receptor agonist with extended half-life. The most-studied incretin analogue in current metabolic research.

AOD-9604

Anti-Obesity Drug

Synthetic fragment of human growth hormone (residues 176-191). Lipolysis research.